Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, South Korea.
Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, South Korea.
Medicine (Baltimore). 2022 Jul 29;101(30):e29596. doi: 10.1097/MD.0000000000029596.
The coronavirus disease 2019 (COVID-19) resulted in a marked decrease in the number of patient visits for acute myocardial infarction and delayed patient response and intervention in several countries. This study evaluated the effect of the COVID-19 pandemic on the number of patients, patient response time (pain-to-door), and intervention time (door-to-balloon) for patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). Patients with STEMI or NSTEMI visiting a hospital in South Korea who underwent primary coronary intervention during the COVID-19 pandemic (January 29, 2020, to December 31, 2020) were compared with those in the equivalent period from 2018 to 2019. Patient response and intervention times were compared for the COVID-19 pandemic window (2020) and the equivalent period from 2018 to 2019. We observed no decrease in the number of patients with STEMI (P = .88) and NSTEMI (P = 1.00) during the COVID-19 pandemic compared to that in the previous years. Patient response times (STEMI: P = .39; NSTEMI: P = .59) during the overall COVID-19 pandemic period did not differ significantly. However, we identified a significant decrease in door-to-balloon time among patients with STEMI (14%; P < .01) during the early COVID-19 pandemic. We found that the number of patients with STEMI and NSTEMI was consistent during the COVID-19 pandemic and that no time delays in patient response and intervention occurred. However, the door-to-balloon time among patients with STEMI significantly reduced during the early COVID-19 pandemic, which could be attributed to decreased emergency care utilization during the early pandemic.
2019 年冠状病毒病(COVID-19)导致许多国家急性心肌梗死(acute myocardial infarction)患者就诊人数明显减少,且患者反应和干预时间延迟。本研究评估了 COVID-19 大流行对 ST 段抬高型心肌梗死(STEMI)和非 ST 段抬高型心肌梗死(NSTEMI)患者人数、患者反应时间(疼痛至入院)和干预时间(入院至球囊扩张)的影响。将韩国一家医院在 COVID-19 大流行期间(2020 年 1 月 29 日至 2020 年 12 月 31 日)接受直接经皮冠状动脉介入治疗的 STEMI 或 NSTEMI 患者与 2018 年至 2019 年同期进行比较。比较 COVID-19 大流行期间(2020 年)与 2018 年至 2019 年同期患者的反应和干预时间。与前几年相比,我们发现 COVID-19 大流行期间 STEMI(P =.88)和 NSTEMI(P = 1.00)患者人数并未减少。STEMI(P =.39)和 NSTEMI(P =.59)患者在整个 COVID-19 大流行期间的反应时间无显著差异。然而,我们发现早期 COVID-19 大流行期间 STEMI 患者的门球时间显著缩短(14%,P <.01)。我们发现 COVID-19 大流行期间 STEMI 和 NSTEMI 患者的数量保持不变,且患者反应和干预没有延迟。然而,STEMI 患者的门球时间在 COVID-19 大流行早期显著缩短,这可能是由于大流行早期紧急护理利用率降低所致。